Skip to main content
Top
Published in: Clinical Rheumatology 9/2013

01-09-2013 | Original Article

Association of clinical features of bone and joint lesions between children and parents with Kashin–Beck disease in Northwest China

Authors: Chun-xia Cao, Yin-gang Zhang, Shi-xun Wu, Mohammad Imran Younas, Xiong Guo

Published in: Clinical Rheumatology | Issue 9/2013

Login to get access

Abstract

We investigated the clinical features of bone and joint lesions in children with Kashin–Beck disease (KBD) and the association of these features with their parents to determine specific clinical features for diagnosing KBD. A total of 2,248 children (4 to 18 years old) and their parents were examined by stratified cluster sampling from 33 villages in six endemic counties and from six villages in a non-endemic county. We collected individual information, clinical symptoms, and radiological signs of the right hand. KBD in children and their parents was assessed using the “Diagnosis Criteria of Kashin–Beck disease in China (WS/T207-2010).” Univariate and multivariate analyses were used to examine the correlation of clinical features between parents and offspring with KBD. The rates of clinical features in children were correlated with those in parents (P < 0.01). The parents of child cases had higher rates of clinical features than the parents of child controls. The prevalence of radiographic alterations in the distal end of the phalanges in the parents of child cases was significantly higher than that in the parents of child controls (father, χ 2 = 14.83, P = 0.001; mother, χ 2 = 10.41, P = 0.001). The parents of child cases were more likely to be KBD cases than the parents of controls (adjusted odds ratio, 4.4–12.1). Recognizing significant correlations in clinical features between children and their parents with KBD is helpful for early clinical diagnosis and evaluation of disease severity. Some clinical features of KBD, such as radiographic alterations in the distal end of the phalanges, might be useful for diagnosing KBD.
Literature
1.
go back to reference Sokoloff L (1989) The history of Kashin-Beck disease. N Y State J Med 89:343–351PubMed Sokoloff L (1989) The history of Kashin-Beck disease. N Y State J Med 89:343–351PubMed
2.
go back to reference Mathieu F, Begaux F, Lan ZY, Sueteus C, Hinsenkamp M (1997) Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet. Int Orthop 21:151–156PubMedCrossRef Mathieu F, Begaux F, Lan ZY, Sueteus C, Hinsenkamp M (1997) Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet. Int Orthop 21:151–156PubMedCrossRef
3.
go back to reference Guo X (2008) Progression and prospect of etiology and pathogenesis of Kashin-Beck disease. J Xi’an Jiaotong Univ Med Sci 29:481–488 Guo X (2008) Progression and prospect of etiology and pathogenesis of Kashin-Beck disease. J Xi’an Jiaotong Univ Med Sci 29:481–488
4.
go back to reference Schepman K, Engelbert RH, Visser MM, Yu C, de Vos R (2011) Kashin Beck disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation. Int Orthop 35:767–776PubMedCrossRef Schepman K, Engelbert RH, Visser MM, Yu C, de Vos R (2011) Kashin Beck disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation. Int Orthop 35:767–776PubMedCrossRef
5.
go back to reference Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25:147–150CrossRef Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25:147–150CrossRef
6.
go back to reference Mathieu F, Begaux F, Suetens C, De Maretelaer V, Hinsenkamp M (2001) Anthropometry and clinical features of Kashin-Beck disease in central Tibet. Int Orthop 25:138–141PubMedCrossRef Mathieu F, Begaux F, Suetens C, De Maretelaer V, Hinsenkamp M (2001) Anthropometry and clinical features of Kashin-Beck disease in central Tibet. Int Orthop 25:138–141PubMedCrossRef
7.
go back to reference Farooq U, Guo X, Chuang LH, Fang H, Zhuang GH, Xia CT (2011) Measuring health-related quality of life in Kashin-Beck disease using EQ-5D. Qual Life Res 20:425–429PubMedCrossRef Farooq U, Guo X, Chuang LH, Fang H, Zhuang GH, Xia CT (2011) Measuring health-related quality of life in Kashin-Beck disease using EQ-5D. Qual Life Res 20:425–429PubMedCrossRef
8.
go back to reference Guo X, Zhang SHY, Mo DX (1993) The role of low selenium in occurrence of Kashin-Beck disease. Chin J Ctrl Endem Dis 8(2):82–84 Guo X, Zhang SHY, Mo DX (1993) The role of low selenium in occurrence of Kashin-Beck disease. Chin J Ctrl Endem Dis 8(2):82–84
9.
go back to reference Voshchenko AV, Ivanov VN (1990) Kashin-Beck disease in the USSR: Proceedings of international workshop on Kashin-Beck disease and non-communicable diseases. World Health Organization 152–196 Voshchenko AV, Ivanov VN (1990) Kashin-Beck disease in the USSR: Proceedings of international workshop on Kashin-Beck disease and non-communicable diseases. World Health Organization 152–196
10.
go back to reference Allander E (1994) Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand J Rheumatol Suppl 99:1–36PubMedCrossRef Allander E (1994) Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand J Rheumatol Suppl 99:1–36PubMedCrossRef
11.
go back to reference Zhai Sh (1990) Investigation on the relationship between Kashin-Beck disease and drinking water. In: Proceedings of international workshop on Kashin-Beck disease and noncommunicable diseases. World Health Organization 96-101 Zhai Sh (1990) Investigation on the relationship between Kashin-Beck disease and drinking water. In: Proceedings of international workshop on Kashin-Beck disease and noncommunicable diseases. World Health Organization 96-101
12.
go back to reference Yasuyuki E (1990) An outline of history of research on Kashin-Beck disease in Japan. In: Proceedings of international workshop on Kashin-Beck disease and non-communicable diseases. World Health Organization 149-151 Yasuyuki E (1990) An outline of history of research on Kashin-Beck disease in Japan. In: Proceedings of international workshop on Kashin-Beck disease and non-communicable diseases. World Health Organization 149-151
13.
go back to reference Zhang WH, Neve J, Xu JP, Vanderpas J, Wang ZL (2001) Selenium, iodine and fungal contamination in Yulin District (People’s Republic of China) endemic for Kashin-Beck disease. Int Orthop 25:188–190PubMedCrossRef Zhang WH, Neve J, Xu JP, Vanderpas J, Wang ZL (2001) Selenium, iodine and fungal contamination in Yulin District (People’s Republic of China) endemic for Kashin-Beck disease. Int Orthop 25:188–190PubMedCrossRef
15.
go back to reference Suetens C, Moreno-Reyes R, Chasseur C, Mathieu F, Begaux F, Haubruge E, Durand MC, Neve J, Vanderpas J (2001) Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet. Int Orthop 25:180–187PubMedCrossRef Suetens C, Moreno-Reyes R, Chasseur C, Mathieu F, Begaux F, Haubruge E, Durand MC, Neve J, Vanderpas J (2001) Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet. Int Orthop 25:180–187PubMedCrossRef
16.
go back to reference Zhao QM, Guo X, Lai JH, Tan WH, Wang WZH, Dang XQ (2012) Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. Clin Rheumatol 31:1051–1057PubMedCrossRef Zhao QM, Guo X, Lai JH, Tan WH, Wang WZH, Dang XQ (2012) Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. Clin Rheumatol 31:1051–1057PubMedCrossRef
17.
go back to reference Zhou ZK, Shen B, Pei FX et al (2009) Relation between affected big joints and classification of Kashin-Beck disease in adults of Tibetan. Chin J Bone Jt Surg 2(5):352–356 Zhou ZK, Shen B, Pei FX et al (2009) Relation between affected big joints and classification of Kashin-Beck disease in adults of Tibetan. Chin J Bone Jt Surg 2(5):352–356
18.
go back to reference Malaisse F, Mathieu F (2008) Big bone disease: a multidisciplinary approach of KBD in Tibet Autonomous Region (P.R. China), vol 15. Les Presses Agronomiques de Gembloux, ASBL, Belgium, pp 70–78 Malaisse F, Mathieu F (2008) Big bone disease: a multidisciplinary approach of KBD in Tibet Autonomous Region (P.R. China), vol 15. Les Presses Agronomiques de Gembloux, ASBL, Belgium, pp 70–78
19.
go back to reference Chinese Ministry of Health (1994) Diagnosis criteria of Kashin-Beck disease. Chin J Endem 13:309 Chinese Ministry of Health (1994) Diagnosis criteria of Kashin-Beck disease. Chin J Endem 13:309
20.
go back to reference Moreno-Reyes R, Suetens C, Mathieu F et al (1998) Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 339:1112–1120PubMedCrossRef Moreno-Reyes R, Suetens C, Mathieu F et al (1998) Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 339:1112–1120PubMedCrossRef
21.
go back to reference Lü AL, Guo X, Aisha MMT, Shi XW, Zhang YZH, Zhang YY (2011) Kashin-Beck disease and Sayiwak disease in China: prevalence and a comparison of the clinical manifestations, familial aggregation, and heritability. Bone 48:347–353PubMedCrossRef Lü AL, Guo X, Aisha MMT, Shi XW, Zhang YZH, Zhang YY (2011) Kashin-Beck disease and Sayiwak disease in China: prevalence and a comparison of the clinical manifestations, familial aggregation, and heritability. Bone 48:347–353PubMedCrossRef
22.
go back to reference Chinese Ministry of Health (2010) Diagnostic criteria of Kashin-Beck disease in China (WS/T207-2010). CMH publication no. 29062-2010 Chinese Ministry of Health (2010) Diagnostic criteria of Kashin-Beck disease in China (WS/T207-2010). CMH publication no. 29062-2010
23.
go back to reference Yang JB, Wang ZW, Liu J, He F (1994) Criteria of diagnosis for Kashin-Beck disease. Chin J Endemicol 13(5):309–317 Yang JB, Wang ZW, Liu J, He F (1994) Criteria of diagnosis for Kashin-Beck disease. Chin J Endemicol 13(5):309–317
24.
go back to reference Yong L, Zhou ZK, Shen B, Yang J, Kang P et al (2012) Clinical features of Kashin-Beck Disease in adults younger than 50 years of age during a low incidence period: severe elbow and knee lesions. Clin Rheumatol. doi:10.1007/s10067-012-2115-0 Yong L, Zhou ZK, Shen B, Yang J, Kang P et al (2012) Clinical features of Kashin-Beck Disease in adults younger than 50 years of age during a low incidence period: severe elbow and knee lesions. Clin Rheumatol. doi:10.​1007/​s10067-012-2115-0
25.
go back to reference Shi XW, Guo X, Ren FL, Lu AL, Zhang YZ (2008) Familial aggregation and sibling heritability in Kashin-Beck disease. Nan Fang Yi Ke Da Xue Xue Bao 28(7):1187–1189PubMed Shi XW, Guo X, Ren FL, Lu AL, Zhang YZ (2008) Familial aggregation and sibling heritability in Kashin-Beck disease. Nan Fang Yi Ke Da Xue Xue Bao 28(7):1187–1189PubMed
26.
go back to reference Zhang JG, Yang YSH (1991) Investigation of the familial aggregation of Kashin-Beck disease. Chin J Ctrl Endem Dis 3:76 Zhang JG, Yang YSH (1991) Investigation of the familial aggregation of Kashin-Beck disease. Chin J Ctrl Endem Dis 3:76
27.
go back to reference Shi XW, Guo X, Lv AL, Kang L, Zhou YL, Zhang YZ, Wu XM, Bai YD (2010) Heritability estimates and linkage analysis of 23 short tandem repeat loci on chromosomes 2, 11, and 12 in an endemic osteochondropathy in China. Scand J Rheumatol 39(3):259–265PubMedCrossRef Shi XW, Guo X, Lv AL, Kang L, Zhou YL, Zhang YZ, Wu XM, Bai YD (2010) Heritability estimates and linkage analysis of 23 short tandem repeat loci on chromosomes 2, 11, and 12 in an endemic osteochondropathy in China. Scand J Rheumatol 39(3):259–265PubMedCrossRef
28.
go back to reference Khoury MJ, Beaty TH, Liang KY (1988) Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127:674–683PubMed Khoury MJ, Beaty TH, Liang KY (1988) Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127:674–683PubMed
29.
go back to reference Guo SW (2000) Familial aggregation of environmental risk factors and familial aggregation of disease. Am J Epidemiol 151:1121–1131PubMedCrossRef Guo SW (2000) Familial aggregation of environmental risk factors and familial aggregation of disease. Am J Epidemiol 151:1121–1131PubMedCrossRef
30.
go back to reference Zhu C (1987) Pathology of Kashin-Beck disease. In: Chen XC (ed) Advancement of pathology. People’s Health, Beijing, p 235 Zhu C (1987) Pathology of Kashin-Beck disease. In: Chen XC (ed) Advancement of pathology. People’s Health, Beijing, p 235
31.
go back to reference Qian Z (1984) A study of radiographic findings in patients with Kashin-Beck disease. J Chin Radiol 18:274 Qian Z (1984) A study of radiographic findings in patients with Kashin-Beck disease. J Chin Radiol 18:274
32.
go back to reference Wang YZ, Yang ZY, Louis AG, Zhu CR (1996) Kashin-Beck disease: radiographic appearance in the hand and wrist. Radiology 201:265–270PubMed Wang YZ, Yang ZY, Louis AG, Zhu CR (1996) Kashin-Beck disease: radiographic appearance in the hand and wrist. Radiology 201:265–270PubMed
33.
go back to reference Cao CX, Guo X, Zhang YZ (2011) Screening and model construction of the clinical diagnostic indictors for Kashin-Beck disease in adolescents. Chin J Endemiol 30(6):43–46 Cao CX, Guo X, Zhang YZ (2011) Screening and model construction of the clinical diagnostic indictors for Kashin-Beck disease in adolescents. Chin J Endemiol 30(6):43–46
34.
go back to reference Gao JQ, Qiu HL, Chen ZW (1994) Epidemiological investigation of Kashin-Beck disease in Qin Xian. ACAD J CZMC 8:309–311 Gao JQ, Qiu HL, Chen ZW (1994) Epidemiological investigation of Kashin-Beck disease in Qin Xian. ACAD J CZMC 8:309–311
35.
go back to reference Ping ZG, Guo X, Wang FQ, Wang ZW (2004) Epidemiological characters of Kashin-Beck disease in nuclear families. Chin Epidemiol 25:848–851 Ping ZG, Guo X, Wang FQ, Wang ZW (2004) Epidemiological characters of Kashin-Beck disease in nuclear families. Chin Epidemiol 25:848–851
36.
go back to reference Wang ZW, Liu YQ, Song JC (1992) Familial aggregation of Kashin-Beck disease and epidemiological significance. Chin J Endem 11:295–296 Wang ZW, Liu YQ, Song JC (1992) Familial aggregation of Kashin-Beck disease and epidemiological significance. Chin J Endem 11:295–296
37.
go back to reference Zhang YZH, Guo X, Ping ZHG et al (2009) Main source of drinking water and familial aggregation of Kashin-Beck disease: a population based on case-control family study. AEP 19(8):560–566PubMed Zhang YZH, Guo X, Ping ZHG et al (2009) Main source of drinking water and familial aggregation of Kashin-Beck disease: a population based on case-control family study. AEP 19(8):560–566PubMed
38.
go back to reference Guo X, Yang YN (2003) Occurrence characteristic of Kashin-beck disease based on nuclear family pedigrees. Acad J Xi’an jiaotong Univ l5:34–37 Guo X, Yang YN (2003) Occurrence characteristic of Kashin-beck disease based on nuclear family pedigrees. Acad J Xi’an jiaotong Univ l5:34–37
Metadata
Title
Association of clinical features of bone and joint lesions between children and parents with Kashin–Beck disease in Northwest China
Authors
Chun-xia Cao
Yin-gang Zhang
Shi-xun Wu
Mohammad Imran Younas
Xiong Guo
Publication date
01-09-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2267-6

Other articles of this Issue 9/2013

Clinical Rheumatology 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine